StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker Inari Medical by Quarter

Inari Medical — U.S. FDA 510(k) Clearances (Ongoing Post-Acquisition, clearances)

QuarterlyAnnualMonthly

Stryker Inari Medical: 2 in Q3 2026.

Latest, Q3 2026
2
Period ended Sep 30, 2026
Change on a year earlier
–
0 in Q3 2025
History
35 quarters
Since Q1 2018
Sources
1
U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical

Where the Q3 2026 figure comes from

Source: U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗

Reported in U.S. FDA openFDA & NIH ClinicalTrials.gov (Inari Medical, through 2026-09).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInari Medical — U.S. FDA 510(k) Clearances (Ongoing Post-Acquisition, clearances)Year on yearSource
Q3 2026Sep 30, 20262–U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q2 2026Jun 30, 20260-100.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q1 2026Mar 31, 20260-100.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q4 2025Dec 31, 20252+100.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q3 2025Sep 30, 20250-100.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q2 2025Jun 30, 20251–U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q1 2025Mar 31, 20251-50.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q4 2024Dec 31, 20241-50.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q3 2024Sep 30, 20241-66.7%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q2 2024Jun 30, 20240-100.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q1 2024Mar 31, 20242-75.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q4 2023Dec 31, 20232–U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q3 2023Sep 30, 202330.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q2 2023Jun 30, 20233+50.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q1 2023Mar 31, 20238+700.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Q4 2022Dec 31, 20220-100.0%U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗

Breakdown

What makes up inari Medical

Cite this data

StockData. (2026). Stryker Inari Medical, quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/nari-fda-510k

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.